Florfenicol
- QJ01BA90 (WHO) QJ51BA90 (WHO)
- AU: S4 (Prescription only)
- Veterinary use only
- 2,2-dichloro-N-[(1R,2S)-3-fluoro-1-hydroxy-1-(4-methanesulfonylphenyl)propan-2-yl]acetamide
- 73231-34-2
N
- 114811
- 102776
Y
- 9J97307Y1H
- D04194
Y
- CHEBI:87185
N
- ChEMBL1241590
N
- DTXSID9045500
![Edit this at Wikidata](http://upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)
- Interactive image
- ClC(Cl)C(=O)N[C@@H]([C@H](O)c1ccc(cc1)S(=O)(=O)C)CF
- InChI=1S/C12H14Cl2FNO4S/c1-21(19,20)8-4-2-7(3-5-8)10(17)9(6-15)16-12(18)11(13)14/h2-5,9-11,17H,6H2,1H3,(H,16,18)/t9-,10-/m1/s1
Y
- Key:AYIRNRDRBQJXIF-NXEZZACHSA-N
Y
![☒](http://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png)
![check](http://upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png)
Florfenicol (marketed by Schering-Plough Animal Health under the trade name Nuflor) is a fluorinated synthetic analog of thiamphenicol,[1] mainly used as a antibiotic in veterinary medicine.
As a generic, it is now available worldwide.[2]
Indications
In the United States, florfenicol is currently indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni, for treatment of bovine interdigital phlegmon (foot rot, acute interdigital necrobacillosis, infectious pododermatitis) associated with Fusobacterium necrophorum and Prevotella melaninogenica.
In swine, it is indicated for the treatment of respiratory infections caused by Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, Glaesserella parasuis, P. multocida, and Streptococcus suis.
Florfenicol is also used in aquaculture, and is licensed for use in the United States for the control of enteric septicemia in catfish.[3]
Since the early 2000s, it has been used in Europe,[4] treating mainly primary or secondary colibacillosis in broiler[5] and parent flocks. It is not allowed in laying hens, due to residues in eggs. It is also indicated in turkey.
The use of florfenicol in horses, and likely in other equids, typically causes diarrhea. This has been anecdotally reported to progress to lethal cases of acute colitis. Therefore, use of this antimicrobial in the equine patient should be limited to cases in which other, safer, options are not available.[6]
Contamination
Florfenicol was among the drug contaminants in a brand of supermarket eggs in Taiwan and Iran.[7]
External links
- Nuflor website
References
- ^ Syriopoulou VP, Harding AL, Goldmann DA, Smith AL (February 1981). "In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol". Antimicrobial Agents and Chemotherapy. 19 (2): 294–297. doi:10.1128/aac.19.2.294. PMC 181412. PMID 6957162.
- ^ "Florfenicol". Drugs.com.
- ^ Gaunt PS, Langston C, Wrzesinski C, Gao D, Adams P, Crouch L, et al. (October 2013). "Multidose pharmacokinetics of orally administered florfenicol in the channel catfish (Ictalurus punctatus)". Journal of Veterinary Pharmacology and Therapeutics. 36 (5): 502–506. doi:10.1111/j.1365-2885.2012.01426.x. PMID 22882087.
- ^ "Florfenicol (Extension to Chicken)" (PDF). Committee for Veterinary Medicinal Products. European Medicines Agency. March 1999. Archived from the original (PDF) on 2018-09-20. Retrieved 2016-05-10.
- ^ Shen J, Wu X, Hu D, Jiang H (October 2002). "Pharmacokinetics of florfenicol in healthy and Escherichia coli-infected broiler chickens". Research in Veterinary Science. 73 (2): 137–140. doi:10.1016/s0034-5288(02)00033-4. PMID 12204631.
- ^ Magdesian KG (2009). "Update on Common Antimicrobials". In Robinson NE, Sprayberry KA (eds.). Current therapy in equine medicine. Saunders Elesevier. p. 13. ISBN 978-1-4160-5475-7. Retrieved March 21, 2011.
- ^ I-chia L (8 January 2013). "Survey suggests certain eggs may be dangerous". Taipei Times. Retrieved 3 November 2014.
- v
- t
- e
Aminoglycosides (initiation inhibitors) |
| ||||||
---|---|---|---|---|---|---|---|
Tetracycline antibiotics (tRNA binding) |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III